Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

1.315 +0.025 (+1.94%)
Streaming Delayed Price Updated: 2:41 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 42,723
Open 1.290
Bid (Size) 1.310 (1)
Ask (Size) 1.320 (10)
Prev. Close 1.290
Today's Range 1.290 - 1.379
52wk Range 1.100 - 16.00
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Insights into Sonnet BioTherapeutics Q4 Earnings
Via Benzinga

Performance

YTD
-17.8%
-17.8%
1 Month
+1.2%
+1.2%
3 Month
-14.1%
-14.1%
6 Month
-53.9%
-53.9%
1 Year
-90.6%
-90.6%

More News

Read More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Down Over 2%; CVS Health Shares Jump After Q3 Results
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Dow Jumps Over 1,200 Points; Donald Trump Wins White House
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Sonnet BioTherapeutics (SONN) Shares Are Down 19% Today
Via Benzinga
Why Greenland Technologies Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket
Via Benzinga
SONN Stock Earnings: Sonnet BioTherapeutics Beats EPS for Q3 2024
Via InvestorPlace
Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
From Sonnet BioTherapeutics Holdings, Inc.
Via GlobeNewswire
Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
From Sonnet BioTherapeutics Holdings, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Gold Rises 1%; Accenture Shares Surge After Q3 Results
Via Benzinga
Dow Edges Lower; US Current Account Deficit Widens In Q1
Via Benzinga
Topics Stocks
Exposures US Equities
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
From Sonnet BioTherapeutics Holdings, Inc.
Via GlobeNewswire
Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
From Sonnet BioTherapeutics Holdings, Inc.
Via GlobeNewswire
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
From Sonnet BioTherapeutics Holdings, Inc.
Via GlobeNewswire
Sonnet BioTherapeutics Announces Review of Strategic Alternatives
Via ACCESSWIRE

Frequently Asked Questions

Is Sonnet BioTherapeutics Holdings, Inc. - Common Stock publicly traded?
Yes, Sonnet BioTherapeutics Holdings, Inc. - Common Stock is publicly traded.
What exchange does Sonnet BioTherapeutics Holdings, Inc. - Common Stock trade on?
Sonnet BioTherapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sonnet BioTherapeutics Holdings, Inc. - Common Stock?
The ticker symbol for Sonnet BioTherapeutics Holdings, Inc. - Common Stock is SONN on the Nasdaq Stock Market
What is the current price of Sonnet BioTherapeutics Holdings, Inc. - Common Stock?
The current price of Sonnet BioTherapeutics Holdings, Inc. - Common Stock is 1.315
When was Sonnet BioTherapeutics Holdings, Inc. - Common Stock last traded?
The last trade of Sonnet BioTherapeutics Holdings, Inc. - Common Stock was at 05/19/25 02:41 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.